Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
0.2746
-0.0055 (-1.96%)
At close: Feb 6, 2026, 4:00 PM EST
0.2767
+0.0021 (0.76%)
After-hours: Feb 6, 2026, 6:57 PM EST
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $55.34 million as of February 6, 2026. Its market cap has decreased by -76.58% in one year.
Market Cap
55.34M
Enterprise Value
61.37M
1-Year Change
-76.58%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $55.34M, a decrease of -87.61%. That is a compound annual growth rate of -40.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 56.45M | -14.20% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 60.39M |
| InflaRx | 59.62M |
| PMV Pharmaceuticals | 57.47M |
| Grace Therapeutics | 57.41M |
| TScan Therapeutics | 56.51M |
| Entera Bio | 56.40M |
| Metagenomi Therapeutics | 55.94M |
| Acrivon Therapeutics | 55.54M |